Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NCF1 | P14598 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | MPO | P05164 | 1/20 | 0.31 |
| ▸ | FBP1 | P09467 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25859255 | 0.88 | CYP1A1 (0.33) | NCF1KDM4EMAPTMEN1ALDH1A1 | |
| SCHEMBL25857355 | 0.87 | PIP4K2A (0.30) | — | |
| SCHEMBL25856890 | 0.85 | ALDH1A1 (0.38) | KDM4EMAPTMEN1ALDH1A1HTT | |
| SCHEMBL31314270 | 0.81 | ALOX5AP (0.41) | NCF1MAPTMEN1ALDH1A1HTT | |
| SCHEMBL25857192 | 0.81 | DHFR (0.37) | NCF1KDM4EMAPTALDH1A1HTT | |
| SCHEMBL31314299 | 0.81 | GABRG2 (0.31) | — | |
| SCHEMBL25858470 | 0.80 | GABRA1 (0.30) | — | |
| SCHEMBL31496024 | 0.80 | CACNA2D1 (0.31) | MEN1KMT2A | |
| SCHEMBL31314251 | 0.79 | CACNA2D1 (0.33) | KMT2A | |
| SCHEMBL25294668 | 0.78 | MAPT (0.32) | KDM4EMAPTALDH1A1HTTKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023131277-A1 | NLRP3 INFLAMMASOME INHIBITOR AND USES THEREOF | 药捷安康(南京)科技股份有限公司 | 2023-07-13 | — | — | WO | disclosed |